Lv1
90 积分 2026-01-09 加入
26875 52-week laboratory safety findings from an open-label extension (OLE) study of dupilumab in adolescent patients with atopic dermatitis (LIBERTY AD PED-OLE)
20天前
已关闭
Remedial Dosing Recommendations for Sirolimus Delayed or Missed DosagesCaused by Poor Medication Compliance in Pediatric Tuberous SclerosisComplex Patients
1个月前
已完结
皖公网安备34019202002308
